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Long-term effects of acute ischemia and reperfusion injury. Is-
chemia reperfusion (I/R) injury plays a major role in delayed
graft function and long-term changes after kidney transplanta-
tion. By using different therapeutic strategies to prevent I/R in-
jury in rat models of kidney transplantation we studied relation-
ships between inflammatory cell arrival and adhesion molecule
expression. In other rat models for acute renal failure we in-
vestigated the effect of up-regulation of protective genes such
as heme oxygenase-1 (HO-1) on infiltrating cells, showing that
infiltrating cells also contribute to beneficial effects. In order
to gain more insight into the complex mechanisms of long-
term changes after kidney transplantation, we started a protocol
biopsy program to study histologic changes 6, 12, and 26 weeks
after transplantation. The following article clarifies some of the
complex mechanisms contributing to long-term changes caused
by I/R injury.
The last years, it has become evident that the cellular
and molecular mechanisms during ischemia and reper-
fusion resemble an acute inflammatory response. Acute
ischemia leads to the activation of the endothelium with
an increase in permeability and expression of different
adhesion molecules [1, 2]. These molecules are crucial for
the recruitment and infiltration of effector cells into the
postischemic tissue [3]. Transcription factors such as nu-
clear factor-jB (NF-jB) are induced and activated lead-
ing to an enhanced expression of inflammatory genes. The
endothelial cells lose their antiadhesive properties and
develop a thrombogenic and adhesive surface. On reper-
fusion, the ischemia-primed endothelial cells are prone
to leukocyte and platelet adhesion, thereby increasing
endothelial cell permeability and cell activation. The ad-
herent leukocytes release reactive oxygen species (ROS)
and a variety of cytokines, enhancing the inflammatory
reaction. Subsequently, the leukocytes transmigrate and
enter the subendothelial space. The acute inflammatory
response then leads to organ dysfunction and, eventually,
to organ failure. Eventually, the ischemia/reperfusion
(I/R) injury is resolved and organ function restored [4].
However, after initial recovery and a period of rela-
tive quiescence, proteinuria may develop and progressive
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morphologic changes begin, including glomerulosclero-
sis, arterial obliteration, and interstitial fibrosis. These
phenomena are accompanied by a reexpression of adhe-
sion molecules, progressive macrophage infiltration and
their associated products, particularly interleukin (IL)-1,
tumor necrosis factor-a (TNF-a), transforming growth
factor-b (TGF-b), and inducible nitric oxide synthase
(iNOS). Monocyte chemoattractant protein-1 (MCP-1)
is subsequently up-regulated, with a dramatic increase in
infiltrating cells.
To what extent the acute cellular alterations persist
long-term and affect organ function at later time points
remain unclear. Long-term effects of I/R injury have been
of special interest in kidney transplantation [5, 6]. Af-
ter removal from the donor the organs rapidly develop
signs of ischemia. Despite adequate cooling and the use
of preservation fluids, the ischemia leads to the above-
described molecular changes in the vasculature and the
interstitium of the organ. Upon reperfusion in the recip-
ient an acute inflammatory response is induced which
may lead to acute renal failure (ARF), the so-called
delayed graft function. Numerous strategies have been
tested to prevent I/R injury and to ameliorate immediate
graft function. Most studies have supported the concept
that inflammatory mechanisms are important mediators
of I/R injury and have shown that inhibition of adhe-
sion molecule expression, decrease of endothelial cell ac-
tivation or prevention of leukocytes adhesion prevent or
ameliorate delayed graft function. However, it is less clear
whether and how these acute effects may affect the long-
term function of the transplanted kidney and whether
I/R injury may play a role in the development of chronic
allograft nephropathy.
I/R INJURY IS A STATE OF INFLAMMATION
AND MAY PERSIST
Transplanted kidneys with prolonged cold or warm
ischemia times are more susceptible to short-term or
long-term deterioration. Clarifying the pathophysiology
of I/R injury and developing new preventive strategies
are highly important. In native organs, numerous experi-
mental and clinical studies showed that I/R constitutes
an acute inflammatory process, involving cell surface
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adhesion molecule expression. In transplanted organs,
the same mechanisms are also involved in subsequently
initiating the rejection process [4]. Although numerous
studies have addressed anti-adhesion strategies in rodent
models of I/R [8, 9], the sequence in which different cell
subsets arrive and their time course in relationship to
I/R have not been extensively studied. We tested the hy-
pothesis that I/R is solely responsible for the activation
of the adhesion cascade and that alloantigen-dependent
mechanisms are not primarily operative in the early
post-transplant period [20]. We addressed differences
between alloantigen-dependent and alloantigen-non-
dependent injury by employing syngeneic (Lewis-to-
Lewis), nonimmunosuppressed, and cyclosporine A
(CsA)-immunosuppressed allogeneic (Fischer-to-Lewis)
models of rat renal transplantation. We investigated the
sequence in which different cell subsets arrived in the
I/R-damaged transplanted kidney. Finally, we studied the
relationship between inflammatory cell arrival and adhe-
sion molecule expression on endothelium and leukocytes
in the time framework of I/R, as well as deterioration and
graft recovery [20]. The affected vessels expressed more
vascular cell adhesion molecule-1 (VCAM-1) and dense
monocytic infiltrates.
ACUTE PREVENTION OF LEUKOCYTE
ADHESION AND LONG-TERM CHANGES
Others and we have recently examined the long-term
effects of an antiadhesive strategy in the prevention of
ARF in experimental kidney transplantation and ob-
served persistence of macrophage infiltration, induc-
tion of major histocompatability complex (MHC) class
molecules and increased interstitial fibrosis 4 weeks af-
ter acute injury [2, 8, 9]. Therapeutic strategies, which
ameliorate endothelial cell dysfunction and cell infiltra-
tion, seem to prevent the long-term damage after I/R
injury [9]. We were able to demonstrate that antisense di-
rected against intercellular adhesion molecule-1 (ICAM-
1) markedly attenuated acute reperfusion injury in an
autotransplanted model and had a profound effect on
long-term outcome. Rats with allograft control kidneys
developed proteinuria with gradual renal failure lead-
ing to death by week 12. We observed infiltrating lym-
phocytes and macrophages, tubular atrophy, interstitial
fibrosis, arteriosclerosis, and glomerular atrophy, sclero-
sis, and obsolescence. Similar chronic changes after I/R
injury have been found by others [10, 21]. A possible
explanation of the long-term effects of I/R is the acute
injury to the glomeruli. I/R injury most likely reduced
the nephron mass in our rats, not only through adhesion
molecule-related events but also by ischemia-induced
tubular necrosis. The effect of reduced nephron mass has
been emphasized in both animal experiments [11] and
observations in transplanted patients [12].
However, from our observation we would favor a role
for monocytes/macrophages in the chronic response to
acute I/R injury. A major finding in our studies was the
massive infiltration of monocytes. Vehicle-treated kid-
neys showed marked monocytic infiltration in the inter-
stitium and around blood vessels. In contrast, kidneys
from animals with an antisense-treated kidney show only
occasional monocytes in the glomeruli and interstitium.
Monocytes are recruited to the tissue during I/R injury
and comprise up to 60% of the cell infiltrate. These
monocytes are recruited by chemokines from activated
endothelium such as MCP-1 and regulated upon activa-
tion, normal T-cell expressed and secreted (RANTES) af-
ter tissue infiltration monocytes mature and differentiate
into resident macrophages. In addition, it has been shown
that tissue macrophages can proliferate, thereby ampli-
fying and prolonging the local inflammatory response.
An important growth factor for macrophage prolifera-
tion is macrophage-colony-stimulating factor (M-CSF)
[13]. The receptor for this growth factor is encoded by
the proto-oncogene c-fms. In an earlier study we have
investigated the expression of c-fms in areas of cardiac
fibrosis [14]. We reasoned that the appearance of c-fms
might be associated with an increase in monocytes. With
in situ hybridization, we were able to show that the c-fms
expression did not emanate from the cardiac myocytes
themselves, but rather from perivascular areas and sites
between the cardiac myocytes. Histochemical staining
with a specific monocyte marker antibody corroborated
the presence of increased monocytes at these sites. Infil-
trating monocytes and macrophages are capable of elab-
orating cytokines, including platelet-derived growth fac-
tor (PDGF). Expression of c-fms is a marker of monocyte
differentiation [15]. Our findings suggest that increased
c-fms expression not only demonstrates the presence of
monocytes but also implies that monocytes display a dif-
ferentiated phenotype with increased cytokine receptor
expression. We suggested that an increase in this prod-
uct could result in proliferation of monocytes within the
perivascular areas of the myocardium. The monocytes
may be integrally involved in the scarring process. The
early interstitial changes in the heart resemble strongly
the interstitial and vascular alterations in the kidneys of
transplants. We observed increased interstitial deposition
of the same collagens both in renal and cardiac fibrosis.
A progressive infiltration of monocytes and macrophages
was identified in the walls of blood vessels and the in-
terstitium. We have not elucidated the initial signal for
monocyte infiltration nor their subsequent behavior. The
signaling may involve the renin-angiotensin-aldosterone
system. Further support for such a hypothesis and a role
of macrophage survival and proliferation comes from a
recent study by Jose et al [16] who observed organ protec-
tion after blockade of the M-CSF receptor in transplanted
animals.
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PROTECTIVE ROLE OF INFILTRATING CELLS
Macrophage infiltration seems not only associated with
tissue damage. It is well established that the cellular infil-
trate after I/R injury consists of several subsets of leuko-
cytes, which may have deleterious or beneficial effects
on the chronic inflammatory process. We recently iden-
tified one of the possible beneficial effects of infiltrating
macrophages. We addressed the question whether acute
treatment during I/R may influence the expression of
protective genes such as heme oxygenase-1 (HO-1). The
HO-1 system is one of the most important cytoprotective
mechanisms. The HO-1 isoform is also known as heat-
shock protein 32 (HSP32). Its expression is relatively low
under physiologic conditions but strongly induced in hy-
poxia, ischemia, inflammation, or radiation [17]. Since we
had previously demonstrated an anti-inflammatory effect
of statins in an animal model of renal injury [18], we in-
vestigated the effects of a statin on acute I/R injury [19].
We observed that three-day statin treatment significantly
ameliorated the decrease in renal function with post-
ischemic acute tubular necrosis and considerably limited
the structural damage after ischemia. Histologically, we
observed that statin treatment reduced damage in the
proximal tubules in the outer medullary stripe, the area
that is most susceptible to hypoperfusion and hypoxia.
Statin treatment clearly reduced the morphologic dam-
age. Inflammatory reactions attributable to I/R injury are
characterized by leukocyte infiltration. In postischemic
ARF, the majority of infiltrating cells are endothelin-1
(ED-1)–positive monocytes and macrophages [20]. We
observed that the statin reduced ED-1–positive cell infil-
tration by >50%, compared with no treatment. Inflam-
matory cell infiltration in I/R injury is accompanied by
significant up-regulation of adhesion molecules [20]. We
observed that activation of the adhesion cascade, as re-
flected by up-regulation of ICAM-1 on the endothelium
of arteries and in the perivascular space, was inhibited
by the statin. The up-regulation of ICAM-1 expression
in glomeruli, the periglomerular area, and the peritubu-
lar interstitium was also prevented. These findings indi-
cated that statins mostly act through the inhibition of
macrophage infiltration. However, when we investigated
the expression of the “protective” gene HO-1, a signif-
icant up-regulation of this gene both on the RNA and
protein level was found. Further analysis of HO-1 expres-
sion showed an increase of HO-1 in larger vessels and in
the interstitial area. Most of the infiltrated macrophages
showed a significant increase in HO-1 while lymphocytes
were not different from untreated control animals. This
finding indicates that the treatment with a statin did not
only reduce the infiltration of monocytes/macrophages
but, at the same time, induces “protective” genes which
may alter cytokine and protease expression in the infil-
trated cells. Such a hypothesis is further supported by our
finding that statins may in vitro induce HO-1 expression.
We also observed less fibrosis after treatment with a
statin. Fibronectin is a major glycoprotein in plasma and
in the extracellular matrix. It plays a role as a chemoat-
tractant for several cell types and generates a scaffold to
which other matrix components can attach. In response
to I/R injury, fibronectin is markedly up-regulated in the
renal interstitium [21]. We observed that cerivastatin ef-
fectively blocked the increased expression of fibronectin
in the tubulointerstitium of the outer medullary stripe.
We also examined collagen IV expression, because ab-
normal collagen turnover is a major histologic feature
in many forms of renal disease. Collagen IV expression
is also predictive for long-term allograft survival. Col-
lagen IV occurs in the renal interstitium, Bowman’s cap-
sule, and tubular basement membranes [22]. We observed
that the increased collagen IV deposition in the peritubu-
lar interstitium after I/R injury was decreased with statin
treatment. We found that I/R is ameliorated by treatment
with a statin and that this strategy not only reduces en-
dothelial cell function and leukocyte infiltration but also
the expression of HO-1 in a subset of infiltrating cells.
PROTOCOL BIOPSIES AS A STRATEGY
TO ANALYZE THE MECHANISMS OF
I/R-INDUCED CHRONIC CHANGES
In order to gain more insight into the cellular and
molecular changes in the early period after transplanta-
tion and analyze the relationship between I/R and chronic
changes protocol biopsies 6 weeks and 3 and 6 months af-
ter renal transplantation were analyzed. Chronic allograft
nephropathy (CAN) leads to chronic allograft dysfunc-
tion and is the most prevalent cause of late renal graft loss.
CAN probably starts early after transplantation, in cor-
relation with donor conditions, such as donor age, brain
death, or I/R injury [22–25], but is found particularly in
the case of early rejections [26–28]. In December 2000,
we therefore started a renal transplant protocol biopsy
program, with the intention of (1) detecting and treat-
ing clinically silent acute rejection episodes [29] and (2)
identifying early mechanisms of CAN.
The protocol biopsies are carried out 6, 12, and
26 weeks after renal transplantation as an outpatient pro-
cedure. Biopsies are performed in the morning using an
18-gauge automated biopsy needle and the patient is kept
in hospital for 4 hours bed-rest with blood pressure and
urine control and carrying out an ultrasound of the kid-
ney before and after biopsy. The histology of the biopsies
was evaluated according to the Banff classification system
[30].
Since December 2000 we have performed 228 trans-
plant biopsies in 108 patients [biopsy 1 (N = 93), biopsy
2 (N = 82), and biopsy 3 (N = 53)]. Fourteen patients
(13%) had several transplants, 14 patients (13%) had
a combined pancreas-kidney transplant and 16 patients
(15%) had a transplant from a living donor. The patient
acceptance rate of the program was 96%. Complications
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Fig. 1. Histopathologic findings in relation to time after renal trans-
plantation (Tx).
of the 228 biopsies were a vasovagal reaction in three
cases with sustained bradycardia or vomiting, macrohe-
maturia in four cases, a perirenal hematoma in ultrasound
in nine cases, and a small arteriovenous fistula in 23 cases.
Hospitalization of the patient due to a biopsy complica-
tion was necessary in four cases. The histologic findings
in relation to time after renal transplantation are shown
in Figure 1. Acute rejections were most often seen in
biopsy 1, chronic changes most often in biopsy 3 (Fig. 1).
Chronic changes such as interstitial fibrosis indicating
CAN were already detected in 52% of biopsies after
6 months. These patients also had a small but signifi-
cant increase in serum creatinine. We then tested whether
cold ischemia time, delayed graft function, donor age, and
other well-established risk factors were related to these
early interstitial changes. So far, no statistical significant
correlation has been observed. These observations indi-
cate that the mechanisms, which induce interstitial fibro-
sis in the months after I/R injury, are still incompletely
understood. We propose that the chronic effects of I/R
depend on the individual response of the kidney to the
insult. Important cellular mechanisms may be the balance
between damaging genes such as oxidases and proteases
and protective genes such as HO-1 and VEGF.
FUTURE DIRECTIONS
Our studies indicate that the cellular and molecular
mechanisms, which persist in the months after I/R injury,
are still unclear. Obviously, the extent of the intitial in-
jury (i.e., the degree of necrosis and apoptosis) plays an
important role. Other possible cellular mechanisms are
shown in Figure 2. Monocyte infiltration seems to be a
prerequisite of fibrosis and subsequent deterioration. An
analysis of the macrophage subsets in the graft and their
gene expression pattern is an important future goal. How-
ever, which mechanisms are responsible for monocyte
survival, which factors are responsible for differentiation
into macrophages and whether in situ proliferation of the
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Fig. 2. Possible mechanisms of ischemic/reperfusion (I/R)-induced
chronic changes.
monocytes is important in the pathogenesis of chronic
nephropathy have to be analyzed further. The hallmark
of chronic changes after ischemia and reperfusion injury
is fibrosis. It seems that the balance between protease ac-
tivity and expression of matrix molecules is important.
We recently began to investigate the role of plasmino-
gen activators in this context [31]. In animal experiments,
it has been shown that plasminogen activator plays an
important role in vascular remodelling and fibrosis af-
ter transplantation [32]. However, with regard to mono-
cytic expression of urokinase-type plasminogen activator
(uPA) and its receptor we have found a wide variation of
individual responses in our protocol biopsies. This obser-
vation supports the concept that the individual cellular
and molecular response to the respective injury plays an
important role in the pathogenesis of CAN. Analysis of
individual patterns of gene expression using microarrays
may be a useful approach to define these “response” pat-
terns.
Structural changes in the kidney after the initial injury
may contribute to the chronic fibrosis and deterioration.
The loss of glomeruli and subsequent increase in “renal
workload” has been proposed by others [11, 12]. How-
ever, capillaries in other areas of the kidney may also be
affected by I/R injury. A rarefication of capillaries has re-
cently been suggested as a critical step in the pathogenesis
of chronic renal disease [33].
It seems unlikely that only one of these mechanisms
is responsible for the induction of fibrosis in kidneys af-
ter I/R injury [34]. The magnitude and the type of injury
play an important role. It will also be necessary to charac-
terize the relationship between types of tissue injury and
to find out how different types of injury influence each
other. It is also important to realize the time of the re-
spective injury. Chronic or repetitive exposure to injury
seems to have a deleterious effect on long-term organ
function. This conceptual approach is especially impor-
tant in kidney transplantation because of the combination
of immunologic and nonimmunologic injury as well as the
effect of the immunosuppressive therapy [35] (Fig. 3). In
addition, individual response patterns may be important.
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Fig. 3. Relationship between immunologic and nonimmunologic
mechanisms in the pathogenesis of chronic allograft nephropathy
(CAN). EC is endothelial cell.
Some kidneys (or some recipients) may be more resistant
to injury than others. Identification of gene expression
patterns over time may be necessary to characterize the
molecular response of each patient and to “tailor-made”
therapeutic strategy.
Reprint requests to Hermann Haller, M.D., Department of Nephrol-
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